Evidence map›Paper›PMID 36983154›Full record

ArticleJournal of clinical medicine2023

Antihyperglycemic Potential of

Shadma Wahab, Mohammad Khalid, Mohammed H Alqarni, Mohamed Fadul A Elagib, Ghadah Khaled Bahamdan, Ahmed I Foudah, Tariq M Aljarba, Mons S Mohamed, Nazik Salih Mohamed, Muhammad Arif

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Life (Basel, Switzerland) · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Shadma WahabDepartment of Pharmacognosy, College of Pharmacy, King Khalid University, Abha 62529, Saudi Arabia.ORCID 0000-0001-9941-2918
Mohammad KhalidDepartment of Pharmacognosy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, P.O. Box 173, Al-Kharj 11942, Saudi Arabia.
Mohammed H AlqarniDepartment of Pharmacognosy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, P.O. Box 173, Al-Kharj 11942, Saudi Arabia.ORCID 0000-0002-7061-9111
Mohamed Fadul A ElagibDepartment of Periodontics and Community Dental Sciences, College of Dentistry, King Khalid University, Abha 61421, Saudi Arabia.
Ghadah Khaled BahamdanDepartment of Periodontics and Community Dental Sciences, College of Dentistry, King Khalid University, Abha 61421, Saudi Arabia.
Ahmed I FoudahDepartment of Pharmacognosy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, P.O. Box 173, Al-Kharj 11942, Saudi Arabia.ORCID 0000-0002-6728-8614
Tariq M AljarbaDepartment of Pharmacognosy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, P.O. Box 173, Al-Kharj 11942, Saudi Arabia.
Mons S MohamedDepartment of Pharmacognosy, Faculty of Pharmacy, University of Khartoum, Khartoum 11111, Sudan.
Nazik Salih MohamedDepartment of Pharmacognosy, Imperial University College, Khartoum 11111, Sudan.
Muhammad ArifDepartment of Pharmacognosy, Faculty of Pharmacy, Integral University, Lucknow 226026, India.ORCID 0000-0003-3368-3867
Prince Sattam Bin Abdulaziz University · SAKing Khalid University · SAIntegral University · INUniversity of Khartoum · SD

Funding

King Khalid University RGP-2-58/43
6 · The paper itself

Abstract

The 11 β- hydroxysteroid dehydrogenase 1 (11 β-HSD1) is hypothesized to play a role in the pathogenesis of type 2 diabetes and its related complications. Because high glucocorticoid levels are a risk factor for metabolic disorders, 11β-HSD1 might be a viable therapeutic target. In this investigation, docking experiments were performed on the main constituents of

Indexed as

11β-HSD1anti-hyperglycemichypoglycemiain silicoin vitroin vivonatural productsSpondias mangifera

Identifiers

PMID36983154
PMCPMC10051293
OpenAlexW4323850636

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.